Dofetilide Dose Reductions and Discontinuation in Obese Compared with Nonobese Patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000001353
Abstract: Abstract: Dofetilide is an antiarrhythmic agent and primarily eliminated renally. Initial dosing is determined by creatinine clearance, calculated by total body weight in the Cockcroft–Gault equation. To date, there is no evidence comparing the dosing… read more here.
Keywords: adjustments compared; body weight; nonobese patients; dose reductions ... See more keywords